MedTrace Logo

Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

NCT05831826 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2023-10-24

No results posted yet for this study

Summary

According to the comprehensive evaluation, the completion of vaccination and the prevention and treatment strategy of integrated traditional Chinese and western medicine have obvious advantages in improving the symptoms of infection in patients with autoimmune diseases, shortening the course of disease and controlling disease activity, and can play a positive role in the whole process of epidemic prevention and treatment. Now the investigators plan to conduct multi-center clinical and basic research to observe the preventive effect and safety of the vaccine on COVID-19, as well as the preventive effect of the combination of traditional Chinese medicine, in order to obtain high-quality evidence-based evidence and provide scientific basis for the clinical value of the drug.

Conditions

Interventions

BIOLOGICAL

the inactivated COVID-19 vaccines

receive the doses of inactivated COVID-19 vaccines

Sponsors & Collaborators

  • Zhejiang Chinese Medical University

    lead OTHER_GOV

Principal Investigators

  • Wumeng Jin · Zhejiang Chinese Medical University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05831826 on ClinicalTrials.gov